A family story: a father-daughter team of radiologists
Foundation - December 10, 2020
When three generations share the same passion, it becomes part of their DNA! Read on to discover the story of Dr. Pierre Robillard and Dr. Julie Robillard, a pair of outstanding radiologists.
The COLCOT study: a world-class discovery made at the Montreal Heart Institute
Foundation - October 8, 2020
Researchers at the Montreal Heart Institute launched a global study titled COLCOT (COLchicine Cardiovascular Outcomes Trial) in 2014. The goal was to determine whether colchicine, a widely available drug, could prevent the risk of heart attacks in patients who had already experienced this kind of event.
5 gift ideas to support sensitive hearts
Foundation - November 26, 2020
The holiday season is just around the corner and the time has come to start thinking of the presents that will go under your Christmas tree. Here are 5 gift ideas that are sure to let your loved ones know you appreciate them while supporting healthy hearts.
Colchicine: a new ally for cardiovascular health
Foundation - October 7, 2020
Colchicine is an orally administered drug which has been garnering a lot of interest in the past few months. It has recently been the subject of scientific studies that have identified new indications. Let’s take a look at this readily available drug that represents a new hope for people with a variety of health conditions.
Questions and answers: type 2 diabetes
Foundation, in collaboration with Dr. Martin Juneau, cardiologist and Director of Prevention at the Institute - November 12, 2020
The statistics for type 2 diabetes are concerning: it is the world’s fifth leading cause of death due in part to the effects it can have on a person’s cardiovascular health. Dr. Martin Juneau, cardiologist and Director of Prevention at the Montreal Heart Institute, answers your questions about this disease that affects approximately 422 million adults in the world.
Questions and answers: COVID-19 and cardiovascular health
Foundation, in collaboration with Dr. Martin Juneau, cardiologist and Director of Prevention at the Institute - October 5, 2020
COVID-19 has had a significant impact on our lives these past months. Because it can be tricky to find out what is actually true among the vast amount of information available, Dr. Martin Juneau, cardiologist and Director of Prevention at the Montreal Heart Institute, answers your questions about the link between the novel coronavirus and heart disease.
Diabetes prevention clinic sponsored by Sun Life: fighting type 2 diabetes, one patient at a time
Foundation - November 1, 2020
In January 2019, the Montreal Heart Institute’s EPIC Centre inaugurated the Diabetes Prevention Clinic sponsored by Sun Life. Its goal is to improve the health of type 2 diabetics and reduce their risks of developing heart disease. Learn more about this multidisciplinary diabetes prevention program.
Simulation-based teaching: major benefits for patients
Foundation, in collaboration with Dr. Serge Doucet, cardiologist and Director of Education at the Institute - September 21, 2020
Over the past few years, simulation-based education has become increasingly popular in the field of medicine. In fact, several articles have demonstrated its value and even suggested that it can reduce the number of errors made during real medical interventions. In this vein, the Institute’s Centre de formation et d’excellence en santé cardiovasculaire will soon offer new courses as part of its Simulation-based teaching program. Numerous healthcare professionals are already interested in the cardiac catheterization program.
5 tips for managing stress and maintaining a healthy heart in times of crisis
Foundation, in collaboration with Dr. Judith Brouillette, psychiatrist - September 7, 2020
Did you know that stress has a direct effect on heart health? Though stress is vital for a healthy life, it can be harmful if it becomes chronic? Here are 5 tips to control stress and keep your heart healthy.
Colcorona genetic study: better understanding the symptoms of COVID-19
Foundation - August 24, 2020
The Colcorona genetic study is taking place at the Montreal Heart Institute’s Beaulieu-Saucier Pharmacogenomics Centre and is led by Dr. Marie-Pierre Dubé. This study invited participants who have already accepted to take part in the Colcorona study to voluntarily contribute their DNA. The study of their DNA will help researchers better understand why some patients develop a more severe form of COVID-19.